Regeneron news in 2026: 29 dated events
The latest Regeneron event on this page is dated Oct 30, 2026. grafa.com reported: Regeneron Q3 Revenue Rises 36% to $5.12 Billion.
Public (REGN)Biotechnology Research10,000+ employeesregeneron.comLinkedIn
Get Regeneron's live signals in Claude or ChatGPT, or by API
What changed at Regeneron this week? Use Autobound signals for regeneron.com.- Dated events
- 31
- Last 90 days
- 12
- Latest
- Oct 30, 2026
Source: Autobound Signal API · 94 signals tracked for Regeneron · updated
News · latest 10
Latest Regeneron news
Showing 10 of 31 dated events. The Signal API returns all of them.
Get them with one API call- Regeneron Q3 Revenue Rises 36% to $5.12 BillionRegeneron Pharmaceuticals reported third-quarter 2026 revenue of $5.116 billion, up 36% year over year.
- Regeneron Extends Agreement with BARDA to Provide Additional Supply of Ebola Treatment Inmazeb® for U.S. PreparednessWith Biomedical Advanced Research and Development Authority
- Regeneron strengthens its presence in Spain with a new headquarters and highlights the strategic role of MadridRegeneron inaugurated its new corporate headquarters in Madrid, Spain.
- REGN Becomes Final Major Drugmaker To Sign Trump’s Drug Pricing PledgeRegeneron committed more than $9 billion to U.S.-based manufacturing and research-and-development infrastructure investments over the coming years.
- Sanofi expands its partnership with Regeneron in an $8 billion dealRegeneron will receive $1 billion upon signing and up to an additional $7 billion in future milestone payments from Sanofi as part of an expanded partnership.
- Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026Regeneron Pharmaceuticals will report its third quarter 2026 financial and operating results on October 30, 2026.
- Paroxysmal Nocturnal Hemoglobinuria Market Forecast Upto 2036: 5 Emerging Therapies Poised to Accelerate Market GrowthRegeneron Pharmaceuticals is developing Pozelimab + Cemdisiran, a potential therapy for paroxysmal nocturnal hemoglobinuria (PNH).
- Regeneron Pharmaceuticals (REGN) Wins FDA Approval For Pasatru In Adult FOPRegeneron Pharmaceuticals received FDA approval for its drug Pasatru (garetosmab grts) to treat adults with fibrodysplasia ossificans progressiva (FOP).
- Veeva Vault CRM Selected by RegeneronWith Veeva Systems
Showing 10 of 31 dated events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Regeneron with the Signal API
One POST /v1/companies/enrich call with regeneron.com returns Regeneron news signals (news), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"regeneron.com","signal_types":["news"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.
Same industry
News at related companies
Questions about Regeneron news
What is the latest news on Regeneron?
What is going on with Regeneron?
Page updated , the date of the newest row on this page.
Source. News articles about the company, one source link per event.
Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.
Data as of .